Endometrial Squamous Cell Carcinoma, also known as squamous cell carcinoma of endometrium, is related to suppressor of tumorigenicity 3 and vulva squamous cell carcinoma. An important gene associated with Endometrial Squamous Cell Carcinoma is CDKN2A (Cyclin Dependent Kinase Inhibitor 2A), and among its related pathways/superpathways are COPI-independent Golgi-to-ER retrograde traffic and HIF1Alpha Pathway. The drugs Nintedanib and Cisplatin have been mentioned in the context of this disorder. Affiliated tissues include cervix, and related phenotype is embryo.